Surgery to remove upper abdomen lymph nodes for ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial studies whether removing lymph nodes in the upper abdomen (hepatoceliac lymph nodes) improves outcomes for people with stage III or IV ovarian, fallopian tube, or primary peritoneal cancer that has spread to those lymph nodes. It also looks at how this surgery works for people with certain types of relapse, often alongside chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 75 years old
- Have confirmed epithelial ovarian, fallopian tube, or primary peritoneal cancer (not low-grade or mucinous)
- Have cancer in the liver/upper-abdomen lymph nodes seen on scans, and surgeons must believe it can be fully removed
- If this is a first treatment situation, you can have had 1 to 3 rounds of neoadjuvant chemotherapy (if it has not progressed)
- Be “platinum sensitive” if the cancer has come back (platinum-free time of 6 months or more)
- Be well enough for surgery and chemo: good blood counts and organ function, and physically able to do daily activities (ECOG 0–2)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of treating advanced ovarian cancer: having surgery first, or having chemotherapy first followed by surgery. The goal is to see which approach improves outcomes for patients.
This trial tests whether adding immunotherapy (a treatment that boosts your immune system) to surgery helps people whose ovarian cancer has returned and is sensitive to chemotherapy. It aims to see if this combination can improve outcomes for patients with certain biomarkers.
This trial checks whether having surgery to remove as much tumor as possible, followed by ongoing targeted treatment, helps people with advanced ovarian (and related) cancers live longer and/or control cancer better. It specifically uses tumor-testing results to match patients and then continues treatment after surgery.
This trial studies whether an additional treatment after surgery can help people with early-stage epithelial ovarian cancer live longer and stay well for more time. It is meant for patients who had a detailed staging operation and are able to start treatment within 8 weeks.
This study tests whether removing enlarged lymph nodes near the heart and lungs during surgery for advanced ovarian cancer can help you live longer and feel better. You must have already had surgery to remove most of your tumor and have specific lymph node changes on imaging.
This trial studies whether removing (dissecting) lymph nodes during surgery can improve care for people with early-stage ovarian cancer that still needs chemotherapy. You may be eligible if you have certain ovarian cancer types and your scans and surgery do not show clearly suspicious lymph nodes.
Hear when a new Epithelial Ovarian Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.